NCT05032794

Brief Summary

Colonoscopy is the technique of choice for the evaluation of the mucosa of the colon. To be able to do the procedure in optimal conditions, it needs to be clean. Therefore, it is necessary to carry out a preparation as safe and tolerable as possible. This preparation generally consists in a low residue diet the days before the colonoscopy and in the intake of a laxative solution. In previous studies, it has been shown that the low residue diet does not play a relevant role as it was considered before. Recent studies demonstrated that reducing the days of low residue diet does not worsen the cleansing and improves the patient experience. The results of this study are required for determining the role of diet restrictive diet in colon cleansing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
553

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 2, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

October 13, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2022

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

10 months

First QC Date

July 15, 2021

Last Update Submit

December 4, 2022

Conditions

Keywords

bowel cleansingDietLow residue diet

Outcome Measures

Primary Outcomes (1)

  • Adequate bowel cleansing

    Bowel cleansing as a rating using the Boston Bowel Preparation Scale above 1 in each segment . This score ranges fron 0 to 3 in each one of the three segments. Zero is the worst outcome and 3 is the best cleansing

    During colonoscopy (At the withdrawal phase)

Secondary Outcomes (9)

  • Diet tolerability as assessed by a likert scale

    The day of the colonoscopy just before beginning

  • Preparation tolerability as assessed by a likert scale and Hatoum et al. survey

    The day of the colonoscopy just before beginning

  • Rate of colonoscopies with adenoma

    With histology report, an average of 4 weeks after colonoscopy

  • Rate of colonoscopies with polyps

    During colonoscopy

  • Cecal intubation time

    During colonoscopy

  • +4 more secondary outcomes

Study Arms (2)

Unrestricted diet

EXPERIMENTAL

The participant is not instructed to follow any dietary recommendation before colonoscopy. But only the restriction and fasting required for sedation.

Other: Unrestricted diet before colonoscopyDrug: Bisacodyl 5 MG

One day low residue diet

ACTIVE COMPARATOR

The participant is instructed to follow a low residue diet the day before the colonoscopy. It will be given a informative document and educated by a nurse.

Other: 1-day low residue dietDrug: Bisacodyl 5 MG

Interventions

Free diet, without restrictions

Unrestricted diet

To follow a diet low in residues / fiber. the day before the colonoscopy.

One day low residue diet

If the participant is at risk of inadequate bowel cleansing, defined by a score of Dik et al ≥ 2 it will be given Bisacodyl 5 milgrams bid for 3 days.

One day low residue dietUnrestricted diet

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals on the early colorectal cancer detection program who agreed to undergo colonoscopy after positive results on the fecal immunochemical test (FIT)

You may not qualify if:

  • Individuals in which colonoscopy, cleansing solution or bisacodyl are contraindicated
  • Subjects that are considered to have a linguistic barrier or to be unable to understand the instructions and / or give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Hospital de Mataró. Consorci Sanitari del Maresme.

Mataró, Barcelona, Spain

Location

Hospital Universitari Parc Taulí

Sabadell, Barcelona, 08208, Spain

Location

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain

Location

Consorci Sanitari de Terrassa

Terrassa, Spain

Location

Hospital Universitary Mutua de Terrassa

Terrassa, Spain

Location

Related Publications (1)

  • Machlab S, Martinez-Bauer E, Lopez P, Ruiz-Ramirez P, Gomez B, Gimeno-Garcia AZ, Pujals MDM, Tanco S, Sargatal L, Perez B, Justicia R, Enguita M, Pique N, Valero O, Calvet X, Campo R. Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial. Endosc Int Open. 2024 Mar 7;12(3):E352-E360. doi: 10.1055/a-2256-5356. eCollection 2024 Mar.

MeSH Terms

Conditions

Intestinal Neoplasms

Interventions

Bisacodyl

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

CresolsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Salvador Machlab

    Corporació Sanitaria Parc Taulí. Universidad Autónoma de Barcelona.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Gastroenterology Consultant

Study Record Dates

First Submitted

July 15, 2021

First Posted

September 2, 2021

Study Start

October 13, 2021

Primary Completion

August 19, 2022

Study Completion

September 1, 2022

Last Updated

December 7, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations